AzTrials
AzTrials

Musculoskeletal ComplicationNCT05994833

Virtual Physical Therapy Support for Runners

A study testing VPT in people with Musculoskeletal Complication, run by University of Florida at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study will compare standard of care of home exercise for running rehabilitation to the combined treatment of home exercise with an individually provided four-session virtual physical therapy support program intervention on pain and physical function movements (controlled dual and single leg squat and lateral… Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Musculoskeletal Complication
What is being tested?
VPT
Could I receive a placebo?
No, everyone receives an active treatment
How many people
85 participants
Where
1 siteUnited States
Study dates
10 Aug 2023to Jun 2030
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age of 18 to 65 years
  • Regularly running at least 12 miles a week prior to development of musculoskeletal complaint.
  • Free of surgical history of surgery to either lower limb
  • No history of major bony injury to the lower limb such as traumatic fracture, within the past 12 months
  • Presence of chronic lower body running related injuries (e.g., patellofemoral pain, IT band syndrome, Achilles tendinitis, chronic lower back pain after running)
  • Body mass index (BMI) <=35 kg/m2

Who cannot join

  • Pregnant women
  • < 18 or 65 years
  • BMI >35 kg/m2
  • Mental disablement (down's syndrome or dementia)
  • Any persons incarcerated, on parole, on probation, or awaiting trial.
  • Individuals with neurologic or degenerative musculoskeletal disease, such as rheumatoid arthritis, muscular dystrophy, or Parkinson's disease.
Show all 9Show fewer
  • Current acute running related or sport related injury (e.g., ankle sprain, hip labral tear, ACL strain during an event or run)
  • Individuals with a history of strong risk factors for poor fracture healing, such as uncontrolled diabetes, chemotherapy, end-stage organ disease, dialysis or smoking
  • Unwilling to forgo your potential in-person therapy visits for a month after enrollment

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Sharareh PhD, PT contact

3522738453

sharareh75@ufl.edu

United States1 site, 1 recruiting
  • University of Florida College of medicine- Dept of PM&R

    Gainesville, Florida, 32607

    Sharareh Sharififar, PhD, PT, 352-273-8453, sharareh75@ufl.edu

    Recruiting

Other trials in United States

About this study

Official title: Virtual Physical Therapy Support for Runners Receiving Gait Analyses for Lower Body Running Related Musculoskeletal Issues

This study will compare standard of care of home exercise for running rehabilitation to the combined treatment of home exercise with an individually provided four-session virtual physical therapy support program intervention on pain and physical function movements (controlled dual and single leg squat and lateral hopping in individuals post running injury. These collective findings will help provide new evidence of the responses to an individually provided virtual PT interventions among runners.

Being tested
VPT

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VPTBehavioural

    The VPT will be comprised of weekly virtual visits with the participant for one month. During the visits, the physical therapist will review the exercises that were prescribed, adherence, provide feedback to the participant as they execute the exercises onscreen and make corrections, make any progression or adjustments to the exercises, review running cues they learned from the testing session and answer any questions. The therapist will also review any new activities that are initiated during the previous week (to control for confounders), changes in musculoskeletal pain and participation in running volume.

Study groups in NCT05994833
Study groupRoleWhat they receive
paper-based standard care exercise programNo interventionNot described
VPTExperimentalNot described
Receives: Behavioral: VPT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline numerical rating scale for pain (NRSpain) at 4 weeks

    A numerical rating scale for pain (NRSpain) will be used to assess changes in lower body related musculoskeletal pain at rest (now, average over the last week) and during weight bearing activity (like walking) on a range of lowest score of 0 (no pain) to 10 (worst pain)

    Measured: Visits 6; one month post enrollment

  2. Change from baseline numerical rating scale for pain (NRSpain) at 6 months

    A numerical rating scale for pain (NRSpain) will be used to assess changes in lower body related musculoskeletal pain at rest (now, average over the last week) and during weight bearing activity (like walking) on a range of lowest score of 0 (no pain) to 10 (worst pain)

    Measured: Visits 7; six months post enrollment

Secondary outcomes (16)
  1. Change from baseline squat quality on single leg (using dominant leg) at 4 weeks

    Squat performance on the single leg (using dominant leg) will be scored on a range of scale 1 (best performance) to 3 (worst performance)

    Measured: visit 6; one month post enrollment

  2. Change from baseline squat quality on single leg (using dominant leg) at 6 months

    Squat performance on the single leg (using dominant leg) will be scored on a range of scale 1 (best performance) to 3 (worst performance)

    Measured: visit 7; six months post enrollment

  3. Change from baseline squat quality on the dual leg at 4 weeks

    Squat performance on the dual leg will be scored on a range of scale 1 (best performance) to 3 (worst performance)

    Measured: visit 6; one month post enrollment

  4. Change from baseline squat quality on the dual leg at 6 months

    Squat performance on the dual leg will be scored on a range of scale 1 (best performance) to 3 (worst performance)

    Measured: visit 7; six months post enrollment

  5. Change from baseline standing stork quality (using dominant leg) at 4 weeks

    Balance performance on the standing stork will be scored on the ranges of excellent to poor scale compared to the normative data published for males/females (Schell \& Leelarthaepin 1994)

    Measured: visit 6; one month post enrollment

  6. Change from baseline standing stork quality (using dominant leg) at 6 months

    Balance performance on the standing stork will be scored on the ranges of excellent to poor scale compared to the normative data published for males/females (Schell \& Leelarthaepin 1994)

    Measured: visit 7; six months post enrollment

  7. Change from baseline hopping quality (using dominant leg) at 4 weeks

    Quality performance on the hopping three times (using dominant leg) and land on the same limb as far as possible will be scored based on the distance hopped, measured at the level of the great toe on a range of scale 1 (best performance) to 3 (worst performance)

    Measured: visit 6; one month post enrollment

  8. Change from baseline hopping quality (using dominant leg) at 6 months

    Quality performance on the hopping three times (using dominant leg) and land on the same limb as far as possible will be scored based on the distance hopped, measured at the level of the great toe on a range of scale 1 (best performance) to 3 (worst performance)

    Measured: visit 7; six months post enrollment

  9. Change from baseline displacement in forward-backward direction during 20 sec of static standing position at 4 weeks

    A markerless motion system will be used. Cameras will be used to collect the backward-forward displacement during 20 sec of static standing on both legs will be analyzed for ability to control static balance.

    Measured: visit 6; one month post enrollment

  10. Change from baseline displacement in forward-backward direction during 20 sec of static standing position at 6 months

    A markerless motion system will be used. Cameras will be used to collect the backward-forward displacement during 20 sec of static standing on both legs will be analyzed for ability to control static balance.

    Measured: visit 7; six months post enrollment

  11. Change from baseline gait speed at 4 weeks

    Spatiotemporal parameters are analyzed [i.e. gait speed (meters/sec), cadence (steps/minute)]

    Measured: visit 6; one month post enrollment

  12. Change from baseline gait speed at 6 months

    Spatiotemporal parameters are analyzed [i.e. gait speed (meters/sec), cadence (steps/minute)]

    Measured: visit 7; six months post enrollment

  13. Change from baseline displacement of the center of gravity in vertical direction at 4 weeks

    Spatiotemporal parameters are analyzed (i.e. center of gravity vertical displacement measured in centimeters)

    Measured: visit 6; one month post enrollment

  14. Change from baseline displacement of the body in vertical direction at 6 months

    Spatiotemporal parameters are analyzed (i.e. center of gravity vertical displacement measured in centimeters)

    Measured: visit 7; six months post enrollment

  15. Change from baseline displacement between strides at 4 weeks

    Spatiotemporal parameters are analyzed (i.e. stride width measured in centimeters)

    Measured: visit 6; one month post enrollment

  16. Change from baseline displacement between strides at 6 months

    Spatiotemporal parameters are analyzed (i.e. stride width measured in centimeters)

    Measured: visit 7; six months post enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Aug 2023
  2. Study start10 Aug 2023
  3. Primary completionAug 2029 (estimated)
  4. Study completionJun 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
85 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05994833
Sponsor's protocol ID
IRB202301005
Status last verified
Apr 2026
First submitted
12 Jun 2023
Last updated
15 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing VPT in people with Musculoskeletal Complication, run by University of Florida at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 15 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Sharareh PhD, PT (3522738453, sharareh75@ufl.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline numerical rating scale for pain (NRSpain) at 4 weeks (time frame: Visits 6; one month post enrollment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in